Doctor profile · Federal record
Dr. Ibrahim Raphael, M.D.
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Wichita, KS
- NPI 1275943144
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
3311 E Murdock St
Wichita, KS 672083054
(316) 274-8325 - Additional location
-
818 N Carriage Pkwy
Wichita, KS 672084500
(316) 651-2250 - Additional location
-
818 N Emporia St Ste 107
Wichita, KS 672143725
(316) 268-5864
Credentials & registration
- NPI registered
- May 2014 — 12 yrs on file
- Profile last updated
- April 3, 2025
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Kansas #04-44140
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275943144. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,871
Distinct HCPCS
10
Medicare allowed
$374,135
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2182 |
Injection, mepolizumab, 1 mg | 3,100 | 15 | $29 | |
J2357 |
Injection, omalizumab, 5 mg | 2,070 | 13 | $38 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 482 | 208 | $110 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 327 | 192 | $74 | |
99291 |
Critical care, first 30-74 minutes | 129 | 83 | $198 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 89 | 86 | $161 | |
96372 |
Injection of drug or substance under skin or into muscle | 82 | 38 | $13 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 80 | 64 | $119 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 73 | 66 | $85 | |
95811 |
Sleep study in sleep lab with continuous airway pressure (6 years or older) | 48 | 48 | $555 |
In context: peer comparison
Among 7 peers in Wichita Pulmonary Disease Physician, average services per provider: 209. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$96
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | 1 | $95.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
309
Patients
25
Total drug cost
$108,866
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pregabalin | Generic | 44 | 0 | $549 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 44 | 12 | $33,333 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 41 | 13 | $801 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 36 | 0 | $18,466 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 29 | 0 | $11,908 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 16 | 0 | $8,395 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | Brand | 15 | 0 | $7,246 |
| Gabapentin | Generic | 14 | 0 | $77 |
| Bevespi Aerosphere (Glycopyrrolate/Formoterol Fum) | Brand | 13 | 0 | $5,837 |
| Flovent Hfa (Fluticasone Propionate) | Brand | 13 | 0 | $5,927 |
Hospital affiliations
Frequently asked questions
What is Dr. Ibrahim Raphael's medical specialty?
Dr. Ibrahim Raphael practices Pulmonary Disease Physician in Wichita, KS.
Where does Dr. Ibrahim Raphael practice?
Dr. Ibrahim Raphael practices at 3311 E Murdock St, Wichita, KS 672083054. Office phone: 3162748325.
What is Dr. Ibrahim Raphael's NPI?
Dr. Ibrahim Raphael's National Provider Identifier (NPI) is 1275943144, issued by NPPES.
Does Dr. Ibrahim Raphael accept Medicare assignment?
Yes. Dr. Ibrahim Raphael accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ibrahim Raphael commonly perform?
Top Medicare-reported procedures in 2023: Injection, mepolizumab, 1 mg (HCPCS J2182); Injection, omalizumab, 5 mg (HCPCS J2357); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233). Source: CMS Medicare Physician & Other Practitioners file.